2-165295905-C-T
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 5P and 16B. PM5PP2PP3_ModerateBP6_Very_StrongBS1BS2
The NM_001040142.2(SCN2A):c.82C>T(p.Arg28Cys) variant causes a missense change. The variant allele was found at a frequency of 0.000359 in 1,613,964 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R28H) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001040142.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SCN2A | NM_001040142.2 | c.82C>T | p.Arg28Cys | missense_variant | 2/27 | ENST00000375437.7 | |
SCN2A | NM_001371246.1 | c.82C>T | p.Arg28Cys | missense_variant | 2/27 | ENST00000631182.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SCN2A | ENST00000375437.7 | c.82C>T | p.Arg28Cys | missense_variant | 2/27 | 5 | NM_001040142.2 | P1 | |
SCN2A | ENST00000631182.3 | c.82C>T | p.Arg28Cys | missense_variant | 2/27 | 5 | NM_001371246.1 |
Frequencies
GnomAD3 genomes AF: 0.000256 AC: 39AN: 152134Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000251 AC: 63AN: 251020Hom.: 1 AF XY: 0.000288 AC XY: 39AN XY: 135650
GnomAD4 exome AF: 0.000369 AC: 540AN: 1461830Hom.: 1 Cov.: 31 AF XY: 0.000329 AC XY: 239AN XY: 727210
GnomAD4 genome AF: 0.000256 AC: 39AN: 152134Hom.: 0 Cov.: 32 AF XY: 0.000229 AC XY: 17AN XY: 74334
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2024 | SCN2A: BS2 - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 24, 2020 | Reported in a male with an autism spectrum disorder as well as in several unaffected family members (Jiang et al., 2013); Missense variants in this gene are often considered pathogenic (Stenson et al., 2014); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 27733563, 30619928, 23849776, 26220970) - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 13, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Seizures, benign familial infantile, 3;C3150987:Developmental and epileptic encephalopathy, 11 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 04, 2024 | - - |
SCN2A-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 27, 2023 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Seizures, benign familial infantile, 3 Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Complex neurodevelopmental disorder Other:1
not provided, no classification provided | literature only | Channelopathy-Associated Epilepsy Research Center | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at